Customer Q&A: Novartis

Novartis has a rich history of investing in the most promising frontiers of science, the most exciting innovations in the business of medicine, and the most significant healthcare needs. As the industry faces acute disruption, the company’s prescription for ongoing success hinges on APIs and microservices. Pascal Bouquet, Global Head of Architecture for Drug Development, answers a few questions about how digital transformation is moving Novartis forward.  

Previous Asset
OneHealthPort delivers secure gateway for API-driven communications
OneHealthPort delivers secure gateway for API-driven communications

OneHealthPort gives healthcare providers seamless data-sharing in the cloud

Next Asset
Axway Track & Trace (GS1 EPCglobal-compliant and certified)
Axway Track & Trace (GS1 EPCglobal-compliant and certified)

Securing the integrity of complex healthcare supply chains and facilitating compliance with global serializ...